Cargando…
Evaluation of the Aptima HBV Quant Assay Compared to Abbott RealTime M2000 HBV Quant Assay and Procleix Ultrio Plus dHBV Assay in Plasma Samples
Analytical performance of hepatitis B virus (HBV) DNA quantitative assay is critical for screening infection and initiating and monitoring antiviral treatment. In this study, the limit of detection (LoD) and linearity of Aptima HBV Quant assay were evaluated, and analytical performance was compared...
Autores principales: | Yan, Ying, Chang, Le, Ji, Huimin, Han, Yang, Wang, Lunan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431630/ https://www.ncbi.nlm.nih.gov/pubmed/35880868 http://dx.doi.org/10.1128/spectrum.01761-22 |
Ejemplares similares
-
Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors
por: Makroo, Raj Nath, et al.
Publicado: (2015) -
Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India
por: Chaurasia, Rahul, et al.
Publicado: (2016) -
Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
por: Park, Joonhong, et al.
Publicado: (2019) -
Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya
por: Mwau, Matilu, et al.
Publicado: (2022) -
Evaluation of the Aptima(®) HIV‐1 Quant Dx assay for HIV‐1 RNA viral load detection and quantitation in plasma of HIV‐1‐infected individuals: A comparison with Abbott RealTime HIV‐1 assay
por: Amendola, Alessandra, et al.
Publicado: (2016)